Johnson & Johnson Ordered to Pay $8 Billion to Man Who Developed Breasts After Taking Risperdal

It's the latest legal blow for the company

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

It’s shaping up to be an expensive few years for Johnson & Johnson.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in